drugset / Trial / NCT06523504
Atropine (0.02%, 0.04%) Combined With Defocus DIMS for Moderate and High Myopia Control
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To evaluate the effectiveness and safety of DIMS, low concentration atropine eye drops,and atropine combined with DIMS in controlling axial length and refraction in children with moderate to high myopia.
Timeline
- Start
- 2024-02-01
- Primary completion
- 2026-03-31
- Completion
- 2026-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atropine | Other / unclassified | 0.02 % | Other |
| Subject | Atropine | Other / unclassified | 0.04 % | Other |